Radiographic benefit and maintenance of clinical benefit with intravenous golimumab therapy in patients with active rheumatoid arthritis despite methotrexate therapy: results up to 1 year of the phase 3, randomised, multicentre, double blind, placebo controlled GO-FURTHER trial

OBJECTIVE: Report on radiographic effects and maintenance of clinical benefit with intravenous golimumab 2 mg/kg+methotrexate (MTX) for up to week (wk) 52 in active rheumatoid arthritis (RA). METHODS: Patients (n=592) with active RA (≥6/66 swollen, ≥6/68 tender joints, C reactive protein (CRP) ≥1.0 ...

Descripción completa

Detalles Bibliográficos
Autores principales: Weinblatt, Michael E, Westhovens, Rene, Mendelsohn, Alan M, Kim, Lilianne, Lo, Kim Hung, Sheng, Shihong, Noonan, Lenore, Lu, Jiandong, Xu, Zhenhua, Leu, Jocelyn, Baker, Daniel, Bingham, Clifton O
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2014
Materias:
Clinical and Epidemiological Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251163/
https://www.ncbi.nlm.nih.gov/pubmed/24001888
http://dx.doi.org/10.1136/annrheumdis-2013-203742

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251163/
https://www.ncbi.nlm.nih.gov/pubmed/24001888
http://dx.doi.org/10.1136/annrheumdis-2013-203742

Ejemplares similares